MG
FOLD

Marex Group’s Amicus Therapeutics FOLD Stock Holding History

Marex Group’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,418
Closed -$180K – 1219
2026
Q1 		$180K Buy
+12,418
New +$178K ﹤0.01% 914

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Marex Group's FOLD Position: Q2 2026 in Review

Marex Group sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 12,418 shares — an estimated $180K sold.

Marex Group first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $180K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Marex Group reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Marex Group sold 12,418 Amicus Therapeutics shares in Q2 2026, an estimated $180K.
  • Marex Group first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
  • Marex Group's Amicus Therapeutics position peaked at $180K in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.